A study involving 390 participants at Nottingham City Hospital in the United Kingdom found that patients who took twice their customary dose of inhaled steroid for 2 weeks when their asthma symptoms flared up did no better, compared with those who continued to take the usual dose. In addition to the regular inhaled steroids, the participants were asked to use a second inhaler when their symptoms worsened. Of the 390 participants, 192 patients were given inhalers containing a steroid, and 198 were given inhalers with a placebo.
The results showed no significant difference in symptoms for those who received the additional inhaled drug, compared with those who received the placebo, the researchers reported in The Lancet (January 24, 2004).
While many states across our nation are engaged in political battles over the recreational use of marijuana, researchers have been busy studying the medical benefits of cannabidiol.
News from the year's biggest meetings
Clinical features with downloadable PDFs